51. Development of thermosensitive poly(n-isopropylacrylamide-co-((2-dimethylamino) ethyl methacrylate))-based nanoparticles for controlled drug release
- Author
-
Cheng-Liang Peng, Ming-Jium Shieh, Han-Min Tsai, Shu-Jyuan Yang, Tsai-Yueh Luo, Wuu-Jyh Lin, and Chia-Fu Lin
- Subjects
Magnetic Resonance Spectroscopy ,Materials science ,Static Electricity ,Radical polymerization ,Nanoparticle ,Antineoplastic Agents ,Bioengineering ,Irinotecan ,Lower critical solution temperature ,Fluorescence ,Absorption ,Mice ,chemistry.chemical_compound ,Polymethacrylic Acids ,Copolymer ,Animals ,Humans ,Nanotechnology ,Organic chemistry ,General Materials Science ,Particle Size ,Electrical and Electronic Engineering ,Mice, Inbred BALB C ,Cell Death ,Mechanical Engineering ,Temperature ,General Chemistry ,Controlled release ,Endocytosis ,Polymerization ,chemistry ,Mechanics of Materials ,Delayed-Action Preparations ,Thermogravimetry ,Drug delivery ,Poly(N-isopropylacrylamide) ,Methacrylates ,Nanoparticles ,Camptothecin ,Female ,HT29 Cells ,Nuclear chemistry - Abstract
Thermosensitive nanoparticles based on poly(N-isopropylacrylamide-co-((2-dimethylamino)ethylmethacrylate)) (poly(NIPA-co-DMAEMA)) copolymers were successfully fabricated by free radical polymerization. The lower critical solution temperature (LCST) of the synthesized nanoparticles was 41 °C and a temperature above which would cause the nanoparticles to undergo a volume phase transition from 140 to 100 nm, which could result in the expulsion of encapsulated drugs. Therefore, we used the poly(NIPA-co-DMAEMA) nanoparticles as a carrier for the controlled release of a hydrophobic anticancer agent, 7-ethyl-10-hydroxy-camptothecin (SN-38). The encapsulation efficiency and loading content of SN-38-loaded nanoparticles at an SN-38/poly(NIPA-co-DMAEMA) ratio of 1/10 (D/P = 1/10) were about 80% and 6.293%, respectively. Moreover, the release profile of SN-38-loaded nanoparticles revealed that the release rate at 42 °C (above LCST) was higher than that at 37 °C (below LCST), which demonstrated that the release of SN-38 could be controlled by increasing the temperature. The cytotoxicity of the SN-38-loaded poly(NIPA-co-DMAEMA) nanoparticles was investigated in human colon cancer cells (HT-29) to compare with the treatment of an anticancer drug, Irinotecan(®) (CPT-11). The antitumor efficacy evaluated in a C26 murine colon tumor model showed that the SN-38-loaded nanoparticles in combination with hyperthermia therapy efficiently suppressed tumor growth. The results indicate that these thermo-responsive nanoparticles are potential carriers for controlled drug delivery.
- Published
- 2011
- Full Text
- View/download PDF